Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Local Stocks
WallStreetSelect 114
WallStreetSelect 114
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Bristol-Myers Squibb
(NY:
BMY
)
60.59
UNCHANGED
Streaming Delayed Price
Updated: 7:00 PM EDT, Apr 30, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
156
Open
60.59
Bid (Size)
59.31 (100)
Ask (Size)
60.59 (500)
Prev. Close
60.59
Today's Range
60.59 - 60.59
52wk Range
42.52 - 62.89
Shares Outstanding
2,222,113,553
Dividend Yield
4.16%
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
Why Bristol Myers Squibb Stock Rocked the Market Today
↗
April 30, 2026
It scored crushing beats on both revenue and profitability in its first quarter.
Via
The Motley Fool
Bristol Myers (BMY) Q1 2026 Earnings Transcript
↗
April 30, 2026
Bristol Myers (BMY) Q1 2026 Earnings Transcript
Via
The Motley Fool
Performance
YTD
+13.3%
+13.3%
1 Month
-0.1%
-0.1%
3 Month
+11.6%
+11.6%
6 Month
+32.8%
+32.8%
1 Year
+20.7%
+20.7%
More News
Read More
Bristol-Myers Squibb (NYSE:BMY) Exceeds Q1 CY2026 Expectations
April 30, 2026
Via
StockStory
Bristol Myers Squibb (NYSE:BMY) Q1 2026 Earnings Beat Driven by Growth Portfolio
↗
April 30, 2026
Via
Chartmill
Topics
Earnings
Bristol Myers Squibb Reports First Quarter Financial Results for 2026
April 30, 2026
From
Bristol Myers Squibb
Via
Business Wire
Earnings To Watch: Bristol-Myers Squibb (BMY) Reports Q1 Results Tomorrow
April 28, 2026
Via
StockStory
3 Healthcare Stocks That Pay You While You Wait for the Growth
↗
April 27, 2026
Via
The Motley Fool
Topics
Intellectual Property
3 Biotech Stocks That Could Benefit from the Patent Cliff
↗
April 27, 2026
Via
MarketBeat
Topics
Intellectual Property
Is Bristol Myers Squibb the Best Bargain in Big Pharma?
↗
April 27, 2026
Via
The Motley Fool
Topics
Intellectual Property
Bristol Myers Squibb: Low Volatility Meets High Dividend Yield
↗
April 26, 2026
Via
The Motley Fool
Topics
Intellectual Property
3 Healthcare Stocks That Pay You a Dividend While You Wait for a Recovery
↗
April 25, 2026
Via
The Motley Fool
Topics
Intellectual Property
World Trade
1 Unpopular Stock That Should Get More Attention and 2 We Question
April 22, 2026
Via
StockStory
Ardelyx Appoints Biopharmaceutical Veteran, Felecia W. Ettenberg, as Chief Legal Officer
April 20, 2026
From
Ardelyx, Inc.
Via
GlobeNewswire
2 Healthcare Stocks to Buy and 1 to Approach With Caution
↗
April 15, 2026
Via
The Motley Fool
J&J Shatters Estimates as Oncology and MedTech Power 2026 Outlook Higher
April 15, 2026
Via
MarketMinute
Topics
Economy
Intellectual Property
The RAS Revolution: A Deep Dive into Revolution Medicines’ Path to Dominance (2026 Report)
April 14, 2026
Via
Finterra
Topics
Economy
Initial Public Offering
Intellectual Property
Which Dividend Pharma Stock Should a Value Investor Choose Today?
↗
April 12, 2026
Via
The Motley Fool
Topics
Intellectual Property
2 Recession Resistant Dividend Stocks to Buy Now While They're Still Cheap
↗
April 10, 2026
Via
The Motley Fool
Topics
Economy
Intellectual Property
Neurocrine Biosciences (NBIX): A New Era in Neuroscience and Endocrinology
April 07, 2026
Via
Finterra
Topics
Earnings
Economy
Intellectual Property
Lilly’s $47.8 Billion Bet: Why the Contessa Acquisition Redefines the Future of Medicine
April 06, 2026
Via
MarketMinute
Topics
Artificial Intelligence
Gilead Extends Tender Offer for Arcellx as Biotech M&A Sentiment Faces a Reality Check
April 06, 2026
Via
MarketMinute
AMN Healthcare Services, DaVita, Bristol-Myers Squibb, Novavax, and AbbVie Shares Plummet, What You Need To Know
April 02, 2026
Via
StockStory
Topics
Government
Stocks
World Trade
The Trillion-Dollar Treatment: A Deep Dive into Eli Lilly and Company (LLY)
April 02, 2026
Via
Finterra
Topics
Artificial Intelligence
Economy
Intellectual Property
3 Value Stocks Walking a Fine Line
April 02, 2026
Via
StockStory
Moderna 2.0: The mRNA Pioneer’s Pivot to Oncology and the Path to 2028 Profitability
March 31, 2026
Via
Finterra
Topics
Initial Public Offering
Frequently Asked Questions
Is Bristol-Myers Squibb publicly traded?
Yes, Bristol-Myers Squibb is publicly traded.
What exchange does Bristol-Myers Squibb trade on?
Bristol-Myers Squibb trades on the New York Stock Exchange
What is the ticker symbol for Bristol-Myers Squibb?
The ticker symbol for Bristol-Myers Squibb is BMY on the New York Stock Exchange
What is the current price of Bristol-Myers Squibb?
The current price of Bristol-Myers Squibb is 60.59
When was Bristol-Myers Squibb last traded?
The last trade of Bristol-Myers Squibb was at 04/30/26 07:00 PM ET
What is the market capitalization of Bristol-Myers Squibb?
The market capitalization of Bristol-Myers Squibb is 134.64B
How many shares of Bristol-Myers Squibb are outstanding?
Bristol-Myers Squibb has 135B shares outstanding.
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.
